EvolutionaryScale's ESM3: A Leap in AI Biology Simulation

June 28, 2024, 3:52 pm
Nature Portfolio
Nature Portfolio
ContentEdTechLearnNewsPagePersonalPublishingResearchScienceTools
Location: United Kingdom, England, London
Employees: 501-1000
Founded date: 1869
Dive into the world of EvolutionaryScale's ESM3, a groundbreaking AI model that simulates 500 million years of evolution in just a fraction of the time.

EvolutionaryScale, a trailblazing AI research lab founded by former Meta engineers, is making waves with the launch of ESM3. This natively multimodal and generative language model is revolutionizing the field of biology by designing novel proteins that would have taken nature millions of years to evolve.

ESM3's capabilities are truly mind-boggling. With the ability to generate a novel green fluorescent protein (esmGFP) that is only 58% similar to known proteins, this model is equivalent to simulating over 500 million years of evolution in a fraction of the time.

But the impact of ESM3 goes beyond just protein design. By harnessing the power of generative AI, EvolutionaryScale is targeting biology to solve some of humanity's biggest challenges, from climate change to cancer. The potential applications of this technology are vast, with pharmaceutical companies standing to benefit the most from the development of novel medicines.

With ESM3's multimodal reasoning power, scientists can now generate new proteins with unprecedented control. From designing enzymes that break down plastic waste to creating fluorescent proteins for cellular imaging, the possibilities are endless.

But the real question remains: how will ESM3 fare in the real world? While the model has been open-sourced in three sizes, its true impact is yet to be seen. Will it revolutionize drug discovery and disease treatment, or will it fall short of expectations?

Only time will tell. But one thing is certain: EvolutionaryScale's ESM3 is a game-changer in the world of AI biology simulation. With the power to simulate millions of years of evolution in a fraction of the time, this model has the potential to reshape the future of medicine and science as we know it.